The Ariadne Labs’ BetterBirth Program has been focused on developing, implementing, and testing the World Health Organization’s (WHO) Safe Childbirth Checklist globally. In 2014, after a successful pilot of the the Checklist in southern India, the BetterBirth study was initiated in Uttar Pradesh, India, at primary and community health centers. The study measured the effectiveness of the BetterBirth Program on uptake of essential birth practices by birth attendants and on early neonatal mortality, maternal mortality, and maternal morbidity. With follow up data on over 300,000 mothers and infants, the BetterBirth trial is one of the largest maternal health trials ever conducted.
During this webinar, Katherine Semaru will discuss the lessons learned from the BetterBirth trial towards increase of quality of maternal and newborn care, and the work still needed to reduce maternal and neonatal morbidity and mortality.
Katherine Semrau, PhD, MPH, is director of the BetterBirth Program at Ariadne Labs. She is an Assistant Professor of Medicine at Harvard Medical School and an Associate Epidemiologist at the Brigham and Women’s Hospital in the Division of Global Health Equity.She led a large randomized controlled trial of a coaching-based intervention to increase use and adherence to the WHO Safe Childbirth Checklist.